Effects of various statins on cytokine-dependent growth and IgE-dependent release of histamine in human mast cells

Authors


P. Valent MD
Department of Internal Medicine I
Division of Hematology and Hemostaseology
Medical University of Vienna
Währinger Gürtel 18-20
A-1090 Vienna
Austria

Abstract

Background:  Statins are inhibitors of hydroxymethylglutaryl coenzyme A (HMG CoA) reductase, a key enzyme in mevalonic acid (MVA)-dependent signaling. Recent data suggest that statins exhibit profound inhibitory effects on growth and function of various immune cells. In the present study, we examined the in vitro effects of five different statins on primary human mast cells (MCs), MC progenitors, and the human MC line HMC-1.

Methods:  Histamine release experiments were conducted on isolated MCs using statins and an anti-immunoglobulin E (IgE) antibody. Culture experiments were performed with stem cell factor (SCF) and interleukin (IL)-6, and cord blood-derived progenitors.

Results:  Preincubation of primary lung MCs with cerivastatin or atorvastatin (1–50 μM) for 24 h resulted in inhibition of anti-IgE-induced release of histamine. The effects of both statins were dose-dependent. Moreover, both statins, and to a lesser degree lovastatin, were found to inhibit the SCF-induced differentiation of MCs from their progenitors. The other statins tested (simvastatin, pravastatin) did not affect mediator release or growth of MCs.

Conclusions:  Cerivastatin and atorvastatin act as inhibitors of growth and function of human MCs.

Ancillary